Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 97 of 5804
-
Friendly mosquitoes take a bite out of dengue in landmark trial
Prevention CompletedThis is a cluster randomized controlled trial (CRCT) to evaluate the efficacy of Wolbachia-infected A. aegypti mosquito releases in reducing the burden of ARBV infection in Brazil over four years. The intervention will be the release of Wolbachia-infected A. aegypti mosquitoes. S…
Phase: NA • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jun 27, 2026 08:00 UTC
-
Could a targeted pill keep High-Risk breast cancer at bay?
Disease control OngoingPatients with breast cancer, who have completed first line therapy (e.g., radiotherapy, chemotherapy, surgery), and who have to be identified with having a high risk of recurrence of cancer, will be eligible for the study. This patient group is currently offered a standard of car…
Phase: PHASE3 • Sponsor: West German Study Group • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New Needle-Based heart treatment could help children with Drug-Resistant heart disease
Disease control CompletedThe primary purpose of this study was to demonstrate the safety and efficacy of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) in children and assessed its performance and functional outcomes in the follow-up. This is a single-arm, single-center study.
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Freezing tumors may boost immunotherapy in advanced lung cancer: new trial
Disease control Recruiting nowThis study aims to compare the one-year survival benefit of the association of cryoablation-pembrolizumab-pemetrexed-carboplatin versus pembrolizumab-pemetrexed-carboplatin in metastatic lung adenocarcinoma patients. This is a multicenter, prospective, open-labeled, 2-arm compar…
Phase: PHASE3 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Triple-Drug cocktail aims to stall aggressive breast cancer
Disease control CompletedTo evaluate the efficacy and safety of nab-paclitaxel plus cisplatin plus carilizumab as first-line treatment in patients with metastatic triple-negative breast cancer.
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Gene therapy shot could end monthly eye injections for wet AMD
Disease control OngoingThis interventional study is being conducted with an investigational gene therapy treatment called ABBV-RGX-314 (also known as RGX-314) and is being developed as a potential one-time gene therapy treatment for neovascular (wet) age-related macular degeneration (wet AMD or nAMD). …
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New antibody could clear toxic proteins from organs in rare disease
Disease control OngoingAL (or light chain) amyloidosis begins in the bone marrow where abnormal proteins misfold and create free light chains that cannot be broken down. These free light chains bind together to form amyloid fibrils that build up in the extracellular space of organs, affecting the kidne…
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Scientists test brain chip to restore sight in the blind
Disease control Recruiting nowThe purpose of this study is to determine the feasibility of producing artificial vision in persons with blindness. Study participants will have wireless electrical stimulators implanted into the cortical vision processing areas of their brains. The ability of the participants to…
Phase: NA • Sponsor: Illinois Institute of Technology • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug shows promise against multiple Hard-to-Treat cancers
Disease control OngoingThis is an open-label, multi-center, multi-cohort, Phase 2 study to evaluate the efficacy and safety of trastuzumab deruxtecan (T-DXd) for the treatment of selected HER2-expressing tumors. This study will consist of Part 1 which includes 7 cohorts of: urothelial bladder cancer, …
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Targeted radiation plus hormone therapy shows promise against resistant prostate cancer
Disease control OngoingThis phase 2 randomised clinical trial will investigate the activity and safety of adding Lu-PSMA to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC) not previously treated with chemotherapy.
Phase: PHASE2 • Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug shows promise in slowing progressive MS disability
Disease control CompletedPrimary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis (PPMS) Secondary Objectives: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonan…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Home heart monitoring could stop deadly fetal heart block in its tracks
Disease control Recruiting nowFetal complete (i.e., third degree, 3°) atrioventricular block (AVB), identified in the 2nd trimester of pregnancy in an otherwise normally developing heart, is almost universally associated with maternal anti-Ro autoantibodies and results in death in a fifth of cases. To date tr…
Phase: PHASE3 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New trial aims to slash COVID-19 deaths and ventilator use
Disease control OngoingThe goal of this project is to rapidly screen promising agents, in the setting of an adaptive platform trial, for treatment of critically ill COVID-19 patients. In this phase 2 platform design, agents will be identified with a signal suggesting a big impact on reducing mortality …
Phase: PHASE2 • Sponsor: QuantumLeap Healthcare Collaborative • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Half-Matched stem cell transplant offers hope for children with blood disorders
Disease control Recruiting nowThis research is being done to learn if a new type of haploidentical transplantation using TCR alpha beta and CD19 depleted stem cell graft from the donor is safe and effective to treat the patient's underlying condition. This study will use stem cells obtained via peripheral blo…
Phase: PHASE2 • Sponsor: Johns Hopkins All Children's Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Half-Matched stem cell transplant offers hope for children with rare immune and metabolic diseases
Disease control Recruiting nowThis research is being done to learn if a new type of haploidentical transplantation using TCR alpha beta and CD19 depleted stem cell graft from the donor is safe and effective to treat the patient's underlying condition. This study will use stem cells obtained via peripheral blo…
Phase: PHASE2 • Sponsor: Johns Hopkins All Children's Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a new drug combo beat standard chemo for kids with AML?
Disease control Recruiting nowThis phase III trial compares standard chemotherapy to therapy with liposome-encapsulated daunorubicin-cytarabine (CPX-351) and/or gilteritinib for patients with newly diagnosed acute myeloid leukemia with or without FLT3 mutations. Drugs used in chemotherapy, such as daunorubici…
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Experimental gene therapy aims to stop bone marrow failure in kids with rare disease
Disease control OngoingThe objective of this study is to assess the therapeutic efficacy of a hematopoietic cell-based gene therapy for patients with Fanconi anemia, subtype A (FA-A). Hematopoietic stem cells from mobilized peripheral blood of patients with FA-A will be transduced ex vivo (outside the…
Phase: PHASE2 • Sponsor: Rocket Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a new drug stop Alzheimer's before it starts? major trial underway
Disease control OngoingThe primary purpose of this study is to determine whether treatment with lecanemab is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Trial) and to determine whether treatment with lecanemab is …
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Engineered immune cells take on Hard-to-Treat lymphoma
Disease control OngoingThis is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/r FL or MZL. The study will be conducted in compliance with the International Council on Harmonisation (ICH) of Technical Requirem…
Phase: PHASE2 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Massive new study aims to outsmart childhood leukemia
Disease control Recruiting nowALLTogether collects the experience of previously successful treatment of infants, children and young adults, with ALL from a number of well-renowned study groups into a new master protocol, which is both a comprehensive system for stratification and treatment of ALL in this age-…
Phase: PHASE3 • Sponsor: Mats Heyman • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC